NO scavenging and the hypertensive effect of hemoglobin-based blood substitutes

Free Radical Biology and Medicine

Volumn 36, Issue 6, 2004, Pages 685-697

  Olson, John S ^a   Foley, Erin W ^a   Rogge, Corina ^b   Tsai, Ah Lim ^b   Doyle, Michael P ^c   Lemon, Douglas D ^c  

^a RICE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c Baxter Hemoglobin Therapeutics Inc   (United States)

Author keywords

Free radicals; Hb, HbO2, deoxyHb, rHb; HbOC; Hemoglobin, oxyhemoglobin, deoxyhemoglobin, recombinant hemoglobin; Hemoglobin based oxygen carrier; MAP; Mb, MbO2; Mean arterial blood pressure; Myoglobin, oxymyoglobin; TPR

Indexed keywords

MYOGLOBIN; NITRIC ACID; PLASMA SUBSTITUTE; RECOMBINANT HEMOGLOBIN; SCAVENGER;

ACIDITY; ALKALINITY; BLOOD FLOW; BLOOD OXYGENATION; BLOOD PRESSURE MONITORING; CARDIOVASCULAR AUTOREGULATION; CHEMICAL REACTION KINETICS; CROSS LINKING; DRUG EFFECT; DRUG MECHANISM; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; MITOCHONDRIAL RESPIRATION; MOLECULAR DYNAMICS; NITROSATION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN ENGINEERING; REACTION ANALYSIS; REVIEW; SIDE EFFECT; STATISTICAL SIGNIFICANCE; VASOCONSTRICTION;

EID: 1342264353     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2003.11.030     Document Type: Review

References (113)

1. Chang T.M. Future generations of red blood cell substitutes. J. Intern. Med. 253:2003;527-535.
2. Chang T.M. Present status of modified hemoglobin as blood substitutes and oral therapy for end stage renal failure using artificial cells containing genetically engineered cells. Ann. N. Y. Acad. Sci. 944:2001;362-372.
3. Chang T.M. Is there a need for blood substitutes in the new millennium and what should we expect in the way of safety and efficacy? Artif. Cells Blood Substit. Immobil. Biotechnol. 28:2000;v-xi.
4. Alayash A.I. Oxidative mechanisms of hemoglobin-based blood substitutes. Artif. Cells Blood Substit. Immobil. Biotechnol. 29:2001;415-425.
5. Alayash A.I. Is there a need for blood substitutes in the new millennium and what should we expect in the way of safety and efficacy? A research perspective. Artif. Cells Blood Substit. Immobil. Biotechnol. 29:2001;1-3.
6. Yeh L.H., Alayash A.I. Redox side reactions of haemoglobin and cell signalling mechanisms. J. Intern. Med. 253:2003;518-526.
7. Winslow R.M. Current status of blood substitute research: towards a new paradigm. J. Intern. Med. 253:2003;508-517.
8. Winslow R.M. Blood substitutes. Curr. Opin. Hematol. 9:2002;146-151.
9. Stowell C.P., Levin J., Spiess B.D., Winslow R.M. Progress in the development of RBC substitutes. Transfusion. 41:2001;287-299.
10. Haney C.R., Buehler P.W., Gulati A. Purification and chemical modifications of hemoglobin in developing hemoglobin based oxygen carriers. Adv. Drug Delivery Rev. 40:2000;153-169.
11. Gulati A., Barve A., Sen A.P. Pharmacology of hemoglobin therapeutics. J. Lab. Clin. Med. 133:1999;112-119.
12. Chang T.M.S. Blood substitutes: principles, methods, products and clinical trials. Vol. 1:1997;Karger-Landes, Basel.
13. Saxena R., Wijnhous A.D., Carton H., Hacke W., Kaste M., Pryzbelski R.J., Stern K.N., Koudstaal P.J. Controlled safety study of a hemoglobin-based oxygen carrier. DCLHb, in acute ischemic stroke. Stroke. 30:1999;993-996.
14. Sloan E.R., Koenigsberg M., Gens D., Cipolle M., Runge J., Mallory M., Rodman G. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA. 282:1999;1857-1864.
15. Hess J.R. Blood substitutes for surgery and trauma: efficacy and toxicity issues. BioDrugs. 12:1999;81-91.
16. Winslow R.M. New transfusion strategies: red cell substitutes. Annu. Rev. Med. 50:1999;337-353.
17. Olson J.S. Genetic engineering of myoglobin as a simple prototype for hemoglobin-based blood substitutes. Artif. Cells Blood Substit. Immobil. Biotechnol. 22:1994;429-441.
18. Olson J.S., Eich R.F., Smith L.P., Warren J.J., Knowles B.C. Protein engineering strategies for designing more stable hemoglobin-based blood substitutes. Artif. Cells Blood Substit. Immobil. Biotechnol. 25:1997;227-241.
19. Doherty D.H., Doyle M.P., Curry S.R., Vali R.J., Fattor T.J., Olson J.S., Lemon D.D. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat. Biotechnol. 16:1998;672-676.
20. Hartman J.C., Argoudelis G., Doherty D., Lemon D., Gorczynski R. Reduced nitric oxide reactivity of a new recombinant human hemoglobin attenuates gastric dysmotility. Eur. J. Pharmacol. 363:1998;175-178.
21. Konomi H., Woods C.M., Meedeniya A.C.B., Giles L.C., Toouli J., Saccone G.T.P. Effects of diaspirin crosslinked hemoglobin on motor function of the duodenum and biliary system in the Australian brush-tailed possum in vivo. J. Pharmacol. Exp. Ther. 296:2001;1067-1073.
22. Conklin J.L., Murray J., Ledlow A., Clark E., Hayek B., Picken H., Rosenthal G. Effects of recombinant human hemoglobin on motor functions of the opossum esophagus. J. Pharmacol. Exp. Ther. 273:1995;762-767.
23. Murray J.A., Ledlow A., Launspach J., Evans D., Loveday M., Conklin J.L. The effects of recombinant human hemoglobin on esophageal motor functions in humans. Gastroenterology. 109:1995;1241-1248.
24. Cullen J.J., Conklin J.L., Murray J., Ledlow A., Rosenthal G. Effects of recombinant human hemoglobin on opossum sphincter of Oddi motor function in vivo and in vitro. Dig. Dis. Sci. 41:1996;289-294.
25. Burhop K., Estep T. Hemoglobin-induced myocardial lesions. Artif. Cells Blood Substit. Immobil. Biotechnol. 29:2001;101.
26. Hess J.R., MacDonald V.W., Brinkley W.W. Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J. Appl. Physiol. 74:1993;1769-1778.
27. Rohlfs R.J., Bruner E., Chiu A., Gonzales A., Gonzales M.L., Magde D., Magde M.D. Jr., Vandegriff K.D., Winslow R.M. Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J. Biol. Chem. 273:1998;12128-12134.
28. Sakai H., Hara H., Yuasa M., Tsai A.G., Takeoka S., Tsuchida E., Intaglietta M. Molecular dimensions of Hb-based O(2) carriers determine constriction of resistance arteries and hypertension. Am. J. Physiol. Heart Circ. Physiol. 279:2000;H908-H915.
29. Vandegriff K.D., Malavalli A., Wooldridge J., Lohman J., Winslow R.M. MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion. 43:2003;509-516.
30. Doyle M.P., Armstrong A.M., Brucker E.A., Fattor T.J., Lemon D.D. Design of second generation recombinant hemoglobin: minimizing nitric oxide scavenging and vasoactivity while maintaining efficacy. (abstract) Artif. Cells Blood Substit. Immobil. Biotechnol. 29:2001;100.
31. Looker D., Mathews A.J., Neway J.O., Stetler G.L. Expression of recombinant human hemoglobin in Escherichia coli. Methods Enzymol. 231:1994;364-374.
32. Caron A., Menu P., Faivre-Fiorina B., Labrude P., Alayash A.I., Vigneron C. Cardiovascular and hemorrheological effects of three modified human hemoglobin solutions in hemodiluted rabbits. J. Appl. Physiol. 86:1999;541-548.
33. Dou Y., Maillett D.H., Eich R.F., Olson J.S. Myoglobin as a model system for designing heme protein based blood substitutes. Biophys. Chem. 98:2002;127-148.
34. Erhart S.M., Cole D.J., Patel P.M., Drummond J.C., Burhop K.E. Effect of alpha-alpha diaspirin crosslinked hemoglobin (DCLHb) on the potency of sodium nitroprusside and nitroglycerine to decrease blood pressure in rats: a dose-response study. Artif. Cells Blood Substit. Immobil. Biotechnol. 28:2000;385-396.
35. Blitzer M.L., Loh E., Roddy M.A., Stamler J.S., Creager M.A. Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans. J. Am. Coll. Cardiol. 28:1996;591-596.
36. Gladwin M.T., Ognibene F.P., Pannell L.K., Nichols J.S., Pease-Fye M.E., Shelhamer J.H., Schechter A.N. Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation. Proc. Natl. Acad. Sci. USA. 97:2000;9943-9948.
37. 2. Proc. Natl. Acad. Sci. USA. 98:2001;355-360.
38. Liao J.C., Hein T.W., Vaughn M.W., Huang K.T., Kuo L. Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc. Natl. Acad. Sci. USA. 96:1999;8757-8761.
39. Liu X., Samouilov A., Lancaster J.R. Jr., Zweier J.L. Nitric oxide uptake by erythrocytes is primarily limited by extracellular diffusion not membrane resistance. J. Biol. Chem. 277:2002;26194-26199.
40. Vaughn M.W., Kuo L., Liao J.C. Effective diffusion distance of nitric oxide in the microcirculation. Am. J. Physiol. 274:1998;H1705-H1714.
41. Kavdia M., Tsoukias N.M., Popel A.S. Model of nitric oxide diffusion in an arteriole: impact of hemoglobin-based blood substitutes. Am. J. Physiol. 282:2002;H2245-H2253.
42. Kharitonov V.G., Sundquist A.R., Sharma V.S. Kinetics of nitric oxide autoxidation in aqueous solution. J. Biol. Chem. 269:1994;5881-5883.
43. Kharitonov V.G., Sundquist A.R., Sharma V.S. Kinetics of nitrosation of thiols by nitric oxide in the presence of oxygen. J. Biol. Chem. 270:1995;28158-28164.
44. Sharma V.S., Traylor T.G., Gardiner R., Mizukami H. Reaction of nitric oxide with heme proteins and model compounds of hemoglobin. Biochemistry. 26:1987;3837-3843.
45. Eich, R. F. Reactions of nitric oxide with myoglobin. Biochemistry and cell biology. Houston: Rice Univ.; 1997: 27-55, 99-110.
46. Eich R.F., Li T., Lemon D.D., Doherty D.H., Curry S.R., Aitken J.F., Mathews A.J., Johnson K.A., Smith R.D., Phillips G.N. Jr., Olson J.S. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry. 35:1996;6976-6983.
47. Joshi M.S., Ferguson T.B. Jr., Han T.H., Hyduke D.R., Liao J.C., Rassaf T., Bryan N., Feelisch M., Lancaster J.R. Jr. Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditions. Proc. Natl. Acad. Sci. USA. 99:2002;10341-10346.
48. Luchsinger B.P., Rich E.N., Gow A.J., Williams E.M., Stamler J.S., Singel D.J. Routes to S-nitroso-hemoglobin formation with heme redox and preferential reactivity in the beta subunits. Proc. Natl. Acad. Sci. USA. 100:2003;461-466.
49. McMahon T.J., Moon R.E., Luschinger B.P., Carraway M.S., Stone A.E., Stolp B.W., Gow A.J., Pawloski J.R., Watke P., Singel D.J., Piantadosi C.A., Stamler J.S. Nitric oxide in the human respiratory cycle. Nat. Med. 8:2002;711-717.
50. Stamler J.S. Hemoglobin and nitric oxide. N. Engl. J. Med. 349:2003;402-405. [Author reply pp. 402-405].
51. Schechter A.N., Gladwin M.T. Hemoglobin and the paracrine and endocrine functions of nitric oxide. N. Engl. J. Med. 348:2003;1483-1485.
52. Huang Z., Louderback J.G., Goyal M., Azizi F., King S.B., Kim-Shapiro D.B. Nitric oxide binding to oxygenated hemoglobin under physiological conditions. Biochim. Biophys. Acta. 1568:2001;252-260.
53. Huang Z., Ucer K.B., Murphy T., Williams R.T., King S.B., Kim-Shapiro D.B. Kinetics of nitric oxide binding to R-state hemoglobin. Biochem. Biophys. Res. Commun. 292:2002;812-818.
54. Gladwin M.T., Lancaster J.R. Jr., Freeman B.A., Schechter A.N. Nitric oxide's reactions with hemoglobin: a view through the SNO-storm. Nat. Med. 9:2003;496-500.
55. Arnold E.V., Bohle D.S., Jordan P.A. Reversible and irreversible hemichrome generation by the oxygenation of nitrosylmyoglobin. Biochemistry. 38:1999;4750-4756.
56. Herold S., Roeck G. Reactions of deoxy-, oxy-, and methemoglobin with nitrogen monoxide. Mechanistic studies of the S-nitrosothiol formation under different mixing conditions. J. Biol. Chem. 278:2003;6623-6634.
57. 2, CO, and NO with hemoglobin. Nagel R.L. Hemoglobin disorders: molecular methods and protocols. 2003;65-91 Humana Press, New York.
58. Herold S. Kinetic and spectroscopic characterization of an intermediate peroxynitrite complex in the nitrogen monoxide induced oxidation of oxyhemoglobin. FEBS Lett. 443:1999;80.
59. ·-mediated oxidation of oxymyoglobin and oxyhemoglobin. Biochemistry. 40:2001;3385-3395.
60. Doyle M.P., Hoekstra J.W. Oxidation of nitrogen oxides by bound dioxygen in hemoproteins. J. Inorg. Biochem. 14:1981;351-358.
61. Gardner A.M., Gardner P.R., Brashear W., Setchell K.D.R., Olson J.S. Fidelity of O-atom transfer in the mechanism of nitric oxide dioxygenation by oxy-hemoglobins. Free Radic. Biol. Med. 31:2001;S78. [Abstract].
62. Gardner P.R., Gardner A.M., Martin L.A., Salzman A.L. Nitric oxide dioxygenase: an enzymic function for flavohemoglobin. Proc. Natl. Acad. Sci. USA. 95:1998;10378-10383.
63. Tsai A.-L., Berka V., Kulmacz R.J., Wu G., Palmer G. An improved sample packing device for rapid freeze-trap electron paramagnetic resonance spectroscopy kinetic measurements. Anal. Biochem. 264:1998;165-171.
64. Alayash A.I., Ryan B.A., Cashon R.E. Peroxynitrite-mediated heme oxidation and protein modification of native and chemically modified hemoglobins. Arch. Biochem. Biophys. 349:1998;65-73.
65. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am. J. Physiol. 271:1996;C1424-C1437.
66. Mehl M., Daiber A., Herold S., Shoun H., Ullrich V. Peroxynitrite reaction with heme proteins. Nitric Oxide. 3:1999;142-152.
67. Richter-Addo G.B. Binding of organic nitroso compounds to metalloporphyrins. Acc. Chem. Res. 32:1999;529-536.
68. Cheng L., Richter-Addo G.B. Binding and activation of nitric oxide by metalloporphyrins and heme. Porphyrin Handbook. 4:2000;219-291.
69. Brittain T., Baker A.R., Butler C.S., Little R.H., Lowe D.J., Greenwood C., Watmough N.J. Reaction of variant sperm-whale myoglobins with hydrogen peroxide: the effects of mutating a histidine residue in the haem distal pocket. Biochem. J. 326:1997;109-115.
70. Miele A.E., Santanch S., Travaglini-Allocatelli C., Vallone B., Brunori M., Bellelli A. Modulation of ligand binding in engineered human hemoglobin distal pocket. J. Mol. Biol. 290:1999;515-524.
71. Looker D.L., Apostol I.Z., Brucker E.A., Doyle M.P., Foster D.L., Glascock C.B., Hartman J.C., Lee G.F., Lemon D.D., Moore E.G., Richards J.P., Schick M.R., Trimble S.P., Pereira D., Hai T.-T., Burhop K.E., Reduced side-effect hemoglobin compositions. PCT Int. Appl. 2001 (Baxter Biotech Technology S.A.R.L., Switzerland). Wo. 0134648, p. 146.
72. Looker D., Abbott-Brown D., Cozart P., Durfee S., Hoffman S., Mathews A.J., Miller-Roehrich J., Shoemaker S., Trimble S., Fermi G.et al. A human recombinant haemoglobin designed for use as a blood substitute. Nature. 356:1992;258-260.
73. 2 transport. Biochemistry and cell biology. 2003;127-165 Rice Univ. Houston.
74. Winslow R.M. Artificial blood: ancient dream, modern enigma. Nat. Biotechnol. 16:1998;621-622.
75. McCarthy M.R., Vandegriff K.D., Winslow R.M. The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: implications for the design of hemoglobin-based oxygen carriers. Biophys. Chem. 92:2001;103-117.
76. Winslow R.M. Blood substitutes. Adv. Drug Delivery Rev. 40:2000;131-142.
77. Winslow R.M. Safety and utility of blood substitutes. Dev. Biol. Stand. 102:2000;167-182.
78. Winslow R.M. Alphaalpha-crosslinked hemoglobin: was failure predicted by preclinical testing? Vox Sang. 79:2000;1-20.
79. Federspiel W.J., Popel A.S. A theoretical analysis of the effect of the particulate nature of blood on oxygen release in capillaries. Microvasc. Res. 32:1986;164-189.
80. 2 transport by hemoglobin in an in vitro capillary system. J. Appl. Physiol. 62:1987;798-806.
81. Hellums J.D., Nair P.K., Huang N.S., Ohshima N. Simulation of intraluminal gas transport processes in the microcirculation. Ann. Biomed. Eng. 24:1996;1-24.
82. 3-exchange across the red cell membrane. Adv. Exp. Med. Biol. 345:1994;167-174.
83. Nair P.K., Hellums J.D., Olson J.S. Prediction of oxygen transport rates in blood flowing in large capillaries. Microvasc. Res. 38:1989;269-285.
84. Nair P.K., Huang N.S., Hellums J.D., Olson J.S. A simple model for prediction of oxygen transport rates by flowing blood in large capillaries. Microvasc. Res. 39:1990;203-211.
85. Doyle M.P., Apostol I., Kerwin B.A. Glutaraldehyde modification of recombinant human hemoglobin alters its hemodynamic properties. J. Biol. Chem. 274:1999;2583-2591.
86. Abassi Z., Kotob S., Pieruzzi F., Abouassali M., Keiser H.R., Fratantoni J.C., Alayash A.I. Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats. J. Lab. Clin. Med. 129:1997;603-610.
87. Matheson B., Kwansa H.E., Bucci E., Rebel A., Koehler R.C. Vascular response to infusions of a nonextravasating hemoglobin polymer. J. Appl. Physiol. 93:2002;1479-1486.
88. Winslow R.M., Gonzales A., Gonzales M.L., Magde M., McCarthy M., Rohlfs R.J., Vandegriff K.D. Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model. J. Appl. Physiol. 85:1998;993-1003.
89. Smith M.L., Long D.S., Damiano E.R., Ley K. Near-wall micro-PIV reveals a hydrodynamically relevant endothelial surface layer in venules in vivo. Biophys. J. 85:2003;637-645.
90. Vink H., Duling B.R. Capillary endothelial surface layer selectively reduces plasma solute distribution volume. Am. J. Physiol. Heart Circ. Physiol. 278:2000;H285-H289.
91. Lew M.J., Rivers R.J., Duling B.R. Arteriolar smooth muscle responses are modulated by an intramural diffusion barrier. Am. J. Physiol. 257:1989;H10-H16.
92. Brunori M. Nitric oxide, cytochrome-c oxidase and myoglobin. Trends Biochem. Sci. 26:2001;21-23.
93. Brunori M. Nitric oxide moves myoglobin centre stage. Trends Biochem. Sci. 26:2001;209-210.
94. Brunori M., Giuffre A., Sarti P., Stubauer G., Wilson M.T. Nitric oxide and cellular respiration. Cell Mol. Life Sci. 56:1999;549-557.
95. Brookes P.S., Kraus D.W., Shiva S., Doeller J.E., Barone M.C., Patel R.P., Lancaster J.R. Jr., Darley-Usmar V. Control of mitochondrial respiration by NO*, effects of low oxygen and respiratory state. J. Biol. Chem. 278:2003;31603-31609.
96. Gardner P.R., Costantino G., Szabo C., Salzman A.L. Nitric oxide sensitivity of the aconitases. J. Biol. Chem. 272:1997;25071-25076.
97. Gardner A.M., Gardner P.R. Flavohemoglobin detoxifies nitric oxide in aerobic, but not anaerobic, Escherichia coli: evidence for a novel inducible anaerobic nitric oxide-scavenging activity. J. Biol. Chem. 277:2002;8166-8171.
98. d, from nitric oxide. J. Biol. Chem. 275:2000;35868-35875.
99. Pathania R., Navani N.K., Gardner A.M., Gardner P.R., Dikshit K.L. Nitric oxide scavenging and detoxification by the Mycobacterium tuberculosis hemoglobin, HbN in Escherichia coli. Mol. Microbiol. 45:2002;1303-1314.
100. Gardner P.R., Gardner A.M., Martin L.A., Dou Y., Li T., Olson J.S., Zhu H., Riggs A.F. Nitric-oxide dioxygenase activity and function of flavohemoglobins. Sensitivity to nitric oxide and carbon monoxide inhibition. J. Biol. Chem. 275:2000;31581-31587.
101. de Figueiredo L.F., Mathru M., Solanki D., Macdonald V.W., Hess J., Kramer G.C. Pulmonary hypertension and systemic vasoconstriction may offset the benefits of acellular hemoglobin blood substitutes. J. Trauma. 42:1997;847-854. (discussion 854-856).
102. Hanzawa K., Ohzeki H., Moro H., Eguchi S., Nakajima T., Makifuchi T., Miyashita K., Nishiura M., Naritomi H. Effects of partial blood replacement with pyridoxalated hemoglobin polyoxyethylene conjugate solution on transient cerebral ischemia in gerbil. Artif. Cells Blood Substit. Immobil. Biotechnol. 25:1997;105-114.
103. Hess J.R., Macdonald V.W., Gomez C.S., Coppes V. Increased vascular resistance with hemoglobin-based oxygen carriers. Artif. Cells Blood Substit. Immobil. Biotechnol. 22:1994;361-372.
104. Jia L., Bonaventura C., Bonaventura J., Stamler J.S. S- nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature. 380:1996;221-226.
105. Reiter C.D., Wang X., Tanus-Santos J.E., Hogg N., Cannon R.O. 3rd, Schechter A.N., Gladwin M.T. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med. 8:2002;1383-1389.
106. Zhang L., Levy A., Rifkind J.M. Autoxidation of hemoglobin enhanced by dissociation into dimers. J. Biol. Chem. 266:1991;24698-24701.
107. Hargrove M.S., Whitaker T., Olson J.S., Vali R.J., Mathews A.J. Quaternary structure regulates hemin dissociation from human hemoglobin. J. Biol. Chem. 272:1997;17385-17389. [Published erratum appears in J. Biol. Chem. 272:24096; 1997].
108. Gattoni M., Boffi A., Sarti P., Chiancone E. Stability of the heme-globin linkage in α-β dimers and isolated chains of human hemoglobin. A study of the heme transfer reaction from the immobilized proteins to albumin. J. Biol. Chem. 271:1996;10130-10136.
109. Bunn H.F., Forget B.G. Hemoglobin: molecular, genetic, and clinical aspects. 1986;Saunders, Philadelphia.
110. Malhotra A.K., Kelly M.E., Miller P.R., Hartman J.C., Fabian T.C., Proctor K.G. Resuscitation with a novel hemoglobin-based oxygen carrier in a swine model of uncontrolled perioperative hemorrhage. J. Trauma. 54:2003;915-924.
111. Resta T.C., Walker B.R., Eichinger M.R., Doyle M.P. Rate of NO scavenging alters effects of recombinant hemoglobin solutions on pulmonary vasoreactivity. J. Appl. Physiol. 93:2002;1327-1336.
112. Wettstein R., Tsai A.G., Erni D., Winslow R.M., Intaglietta M. Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters. Crit. Care Med. 31:2003;1824-1830.
113. Herold S., Matsui T., Watanabe Y. Peroxynitrite isomerization catalyzed by His64 myoglobin mutants. J. Am. Chem. Soc. 123:2001;4085-4086.